Cargando…
Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
British Journal of Anaesthesia. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560257/ https://www.ncbi.nlm.nih.gov/pubmed/33070948 http://dx.doi.org/10.1016/j.bja.2020.09.021 |
| _version_ | 1783595045488689152 |
|---|---|
| author | Lambert, David Calo, Girolamo |
| author_facet | Lambert, David Calo, Girolamo |
| author_sort | Lambert, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7560257 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | British Journal of Anaesthesia. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75602572020-10-16 Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults Lambert, David Calo, Girolamo Br J Anaesth Correspondence British Journal of Anaesthesia. Published by Elsevier Ltd. 2020-12 2020-10-15 /pmc/articles/PMC7560257/ /pubmed/33070948 http://dx.doi.org/10.1016/j.bja.2020.09.021 Text en © 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Lambert, David Calo, Girolamo Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title | Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title_full | Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title_fullStr | Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title_full_unstemmed | Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title_short | Approval of oliceridine (TRV130) for intravenous use in moderate to severe pain in adults |
| title_sort | approval of oliceridine (trv130) for intravenous use in moderate to severe pain in adults |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560257/ https://www.ncbi.nlm.nih.gov/pubmed/33070948 http://dx.doi.org/10.1016/j.bja.2020.09.021 |
| work_keys_str_mv | AT lambertdavid approvalofoliceridinetrv130forintravenoususeinmoderatetoseverepaininadults AT calogirolamo approvalofoliceridinetrv130forintravenoususeinmoderatetoseverepaininadults |